SCHEMBL24784358

SCHEMBL24784358

CCOc1cc(C)c(O)c(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX5 P09917 8/20 0.41
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
BACE1 P56817 1/20 0.39
ESR1 P03372 2/20 0.39
ESR2 Q92731 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
MAPK1 P28482 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589851 0.89 KDM4E (0.40) TSHRCYP3A4HSD17B10ALDH1A1KDM4E
SCHEMBL25329980 0.84 PTGS1 (0.45) TSHRALOX5HSD17B10ALDH1A1KDM4E
SCHEMBL25329730 0.84 KDM4E (0.38) TSHRCYP3A4ALOX5HSD17B10ALDH1A1
SCHEMBL689246 0.82 ESR1 (0.47) ALOX5ALDH1A1KDM4EMAPTESR1
SCHEMBL30356497 0.82 TSHR (0.38) TSHRCYP3A4HSD17B10ALDH1A1KDM4E
SCHEMBL30367452 0.82 ESR1 (0.47) ALOX5ALDH1A1KDM4EMAPTESR1
SCHEMBL28058188 0.82 TSHR (0.46) TSHRHSD17B10ALDH1A1KDM4EMAPT
SCHEMBL16379032 0.80 TSHR (0.39) TSHRCYP3A4HSD17B10ALDH1A1KDM4E
SCHEMBL25328532 0.80 TSHR (0.41) TSHRCYP3A4HSD17B10ALDH1A1KDM4E
Hx-1171 SCHEMBL688955 0.80 ESR1 (0.50) ALOX5ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583813-B2 Polymerization inhibitors BASF SE (DE) 2026-03-24 US disclosed
CN-118108589-A Preparation method of vitamin E intermediate 2,3, 5-trimethylbenzoquinone 浙江新和成药业有限公司 2024-05-31 CN disclosed
US-20230242472-A1 POLYMERIZATION INHIBITORS BASF SE (DE) 2023-08-03 US disclosed
EP-4161892-A1 POLYMERIZATION INHIBITORS BASF SE (DE) 2023-04-12 EP disclosed
CN-115697954-A Polymerization inhibitor 巴斯夫欧洲公司 2023-02-03 CN disclosed
WO-2022265178-A1 TRAP1 INHIBITOR AND USE THEREOF 주식회사 스마틴바이오 2022-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242472-A1 POLYMERIZATION INHIBITORS RCE1, CABLES1, DPYD TSHR 4882/4885CYP3A4 2975/4885ALOX5 1518/4885
US-12583813-B2 Polymerization inhibitors PTGS1, PTGER1, POT1 TSHR 4664/4885CYP3A4 1439/4885ALOX5 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.